Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Critical Reviews in Oncology/Hematology
|
April 9, 2013
Mismatch repair status and clinical outcome in endometrial cancer: a systematic review and meta-analysis
Ivan Diaz-Padilla, Nuria Romero, Eitan Amir, et al.
Gynecologic Oncology
|
May 5, 2012
Ovarian low-grade serous carcinoma: a comprehensive update
Ivan Diaz-Padilla, Anais L Malpica, Lucas Minig, et al.
Ecancermedicalscience
|
January 4, 2014
Borderline tumours of the ovary, current controversies regarding their diagnosis and treatment
María Guadalupe Patrono, Lucas Minig, Ivan Diaz-Padilla, et al.
British Journal of Cancer
|
May 27, 2021
Phase 1 study of the ATR inhibitor berzosertib (formerly M6620, VX-970) combined with gemcitabine ± cisplatin in patients with advanced solid tumours
Mark R Middleton, Emma Dean, Thomas R J Evans, et al.
British Journal of Cancer
|
May 27, 2021
Phase 1 study of the ATR inhibitor berzosertib in combination with cisplatin in patients with advanced solid tumours
Geoffrey I Shapiro, Robert Wesolowski, Craig Devoe, et al.
Journal of the National Cancer Institute
|
November 26, 2013
Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis
Francisco E Vera-Badillo, Arnoud J Templeton, Paulo de Gouveia, et al.
Investigational New Drugs
|
February 12, 2022
Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors
Saiama N Waqar, Clifford Robinson, Anthony J Olszanski, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 11, 2021
A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer
Ruth Plummer, Emma Dean, Hendrik-Tobias Arkenau, et al.
Journal for Immunotherapy of Cancer
|
August 11, 2025
First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors
Michele Maio, Victor Moreno, Juan Martin-Liberal, et al.
JTO Clinical and Research Reports
|
October 13, 2025
Long-term Survival Analysis From PERLA, A Phase II Randomized Trial of Dostarlimab With Chemotherapy Versus Pembrolizumab With Chemotherapy in Metastatic Nonsquamous NSCLC
Sun Min Lim, Ana Laura Ortega Granados, Gustavo Dix Junqueira Pinto, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Critical Reviews in Oncology/Hematology
|
April 9, 2013
Mismatch repair status and clinical outcome in endometrial cancer: a systematic review and meta-analysis
Ivan Diaz-Padilla, Nuria Romero, Eitan Amir, et al.
Gynecologic Oncology
|
May 5, 2012
Ovarian low-grade serous carcinoma: a comprehensive update
Ivan Diaz-Padilla, Anais L Malpica, Lucas Minig, et al.
Ecancermedicalscience
|
January 4, 2014
Borderline tumours of the ovary, current controversies regarding their diagnosis and treatment
María Guadalupe Patrono, Lucas Minig, Ivan Diaz-Padilla, et al.
British Journal of Cancer
|
May 27, 2021
Phase 1 study of the ATR inhibitor berzosertib (formerly M6620, VX-970) combined with gemcitabine ± cisplatin in patients with advanced solid tumours
Mark R Middleton, Emma Dean, Thomas R J Evans, et al.
British Journal of Cancer
|
May 27, 2021
Phase 1 study of the ATR inhibitor berzosertib in combination with cisplatin in patients with advanced solid tumours
Geoffrey I Shapiro, Robert Wesolowski, Craig Devoe, et al.
Journal of the National Cancer Institute
|
November 26, 2013
Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis
Francisco E Vera-Badillo, Arnoud J Templeton, Paulo de Gouveia, et al.
Investigational New Drugs
|
February 12, 2022
Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors
Saiama N Waqar, Clifford Robinson, Anthony J Olszanski, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 11, 2021
A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer
Ruth Plummer, Emma Dean, Hendrik-Tobias Arkenau, et al.
Journal for Immunotherapy of Cancer
|
August 11, 2025
First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors
Michele Maio, Victor Moreno, Juan Martin-Liberal, et al.
JTO Clinical and Research Reports
|
October 13, 2025
Long-term Survival Analysis From PERLA, A Phase II Randomized Trial of Dostarlimab With Chemotherapy Versus Pembrolizumab With Chemotherapy in Metastatic Nonsquamous NSCLC
Sun Min Lim, Ana Laura Ortega Granados, Gustavo Dix Junqueira Pinto, et al.
Page
of 4